Bone Marrow Concentrate (BMC) Injection in Intervertebral Discs

Inclusion Criteria: * A high index of suspicion for discogenic pain, i.e. painful degenerative discs with or without protrusions/herniations and facet/sacroiliac joint pain * Patients with mild to severe spinal stenosis * Patients with radiculopathy * Patients with disc extrusions * Patients with failed spinal fusion * Patients with mild to severe facet arthropathy * Patients with suspected sacroiliac joint disease * Age 18 to 60 years * Mild to severe loss of intervertebral disc height * Pain is not responsive to conservative treatment measures (oral medication, epidural steroid injections, physical therapy) * Pain persists for an extended period of time (i.e., at least 3 months) * High intensity zone (HIZ) in annular fissure or adjacent to annular fissure detected on T2 or STIR MRI * No evidence of contraindications to undergo procedure such as pregnancy, active infection, bleeding disorder, or metastatic cancer * English speaking Exclusion Criteria: * Spinal Deformity (Scoliosis \>20 degrees, Spondylolisthesis) * Sequestered fragments, severe thecal sac compression * Severe neurologic deficit * Non-English speaking * Bone marrow disorders * Immunosuppressed Patients * Patients with coagulopathy * Localized infection in the area of skin penetration * Spinal infection * Serious medical co-morbidities